Skip to main content
Equibles

ALPS ADVISORS INC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1376113 Denver, CO
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$783,445
-$100,683 QoQ
Shares Held
54,068
-15.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 239 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $10,837,032 across 10 Drug Manufacturers - Specialty & Generic names. RDY ranks #4 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BCRX
Biocryst Pharmaceuticals Inc
 317,960 $3,179,600
2 ZTS
Zoetis Inc.
 29,756 $2,138,266
3 AMLX
Amylyx Pharmaceuticals, Inc.
 112,447 $2,019,548
4 RDY
Dr Reddys Laboratories Ltd
This page 		54,068 $783,445
5 UTHR
UNITED THERAPEUTICS Corp
 1,405 $761,271
6 ANIP
Ani Pharmaceuticals Inc
 7,125 $589,807
7 COLL
Collegium Pharmaceutical, Inc
 14,552 $526,782
8 PAHC
Phibro Animal Health Corp
 10,131 $318,113

All Filings in RDY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $783,445 54,068
2026-03-31 $884,128 63,836
2025-12-31 $885,025 63,036
2024-09-30 $529,295 6,662
2024-06-30 $530,434 6,962
2024-03-31 $498,926 6,802
2023-12-31 $577,166 8,295
2023-09-30 $752,488 11,253
2023-06-30 $815,065 12,915
2023-03-31 $763,829 13,417
2022-12-31 $522,675 10,100
2021-09-30 $519,296 7,972
2021-06-30 $521,332 7,092
2021-03-31 $469,326 7,645
2020-12-31 $466,236 6,540